Category: Living

Array BioPharma and Amgen Partner in Type 2 Diabetes

Array BioPharma Inc. and Amgen Inc. announced that they entered into an agreement granting Amgen exclusive worldwide rights to Array's small-molecule glucokinase activator program, including ARRY-403, currently being tested in a Phase 1 clinical trial in patients with type 2 diabetes. Amgen will pay $60 million up-front with additional potential milestones and royalties payments to Array...
0 Shares
What's For Dinner? 1

What’s For Dinner?

Eating is of such vital importance, not just for survival, but a part of our lives’ enjoyment and entertainment, that I set out to make sure that my taste buds were not insulted. The Christmas presents from me that year would be the top notch foodstuffs for a diabetic diet...
0 Shares

EyeSmart EyeCommitted

Diabetic retinopathy is the leading cause of new cases of legal blindness in working-age Americans, and more than half of all people living with diabetes do not get the recommended annual dilated eye exams.
0 Shares

Senate Passes Women’s Health Amendment

The US Senate approved an amendment, put forward by Senator Barbara Mikulski, Democrat of Maryland, that would require insurance companies to offer free mammograms and other preventive services including annual diabetes screening...
0 Shares